Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 66 Cyclophosphamide 44 Cisplatin 43 Nivolumab 36 Paclitaxel 32 Carboplatin 31 Radiotherapy 29 Gemcitabine 28 Docetaxel 25 Dexamethasone 22 atezolizumab 21 Doxorubicin 19 Bevacizumab 19 Magnetic Resonance Spectroscopy 17 fludarabine 16 Vincristine 16 Lenalidomide 16 Etoposide 16 Radiosurgery 15 Letrozole 15 Ipilimumab 15 Fluorouracil 15 Blood Specimen Collection 15 palbociclib 14 Rituximab 14 Radiation 14 Leucovorin 14 Cytarabine 14 Surveys and Questionnaires 13 Specimen Handling 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × NPI 2358 × 90 days × Clear all

NCT02504489 2026-05-19

DUBLIN-3

BeyondSpring Pharmaceuticals Inc.

Phase 3 Completed

559 enrolled 32 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡